Geoffrey Martha - Aug 1, 2022 Form 4 Insider Report for Medtronic plc (MDT)

Role: Chairman and CEO, Director
Signature: /s/ Thomas L. Osteraas, attorney-in-fact
Stock symbol: MDT
Transactions as of: Aug 1, 2022
Transactions value $: $0
Form type: 4
Date filed: 8/3/2022, 05:22 PM
Previous filing: Aug 2, 2022
Next filing: Aug 2, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MDT	Ordinary Shares	Award	$0	+28.5K	+38.46%	$0.00	102K	Aug 1, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MDT	Performance Share Units	Award	$0	+71.2K		$0.00	71.2K	Aug 1, 2022	Performance Share Units	71.2K		Direct	F2, F3, F4
transaction	MDT	Stock Option (Right to Buy)	Award	$0	+225K		$0.00	225K	Aug 1, 2022	Ordinary Shares	225K	$93.08	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.
F2	Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
F3	The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 71,176 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
F4	Vests on August 1, 2025.
F5	These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.